• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Mylan stock sinks 2% after FDA fails to approve its generic asthma medication

    UPDATE: Mylan stock sinks 2% after FDA fails to approve its generic asthma medication

  2. Gastroesophageal Reflux Disease (GERD) Therapeutics Market - Analysis By Drug Type, Region & Segment Forecasts to 2025 - Research and Markets

    Gastroesophageal Reflux Disease (GERD) Therapeutics Market - Analysis By Drug Type, Region & Segment Forecasts to 2025 - Research and Markets

  3. PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 Programs

    PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 Programs

  4. Global Chiral Chemicals Market Analysis 2016 - Forecast to 2022 - Research and Markets

    Global Chiral Chemicals Market Analysis 2016 - Forecast to 2022 - Research and Markets

  5. Global Surgical Operating Microscopes Market (2016-2022) - Driven by Growth in Minimally Invasive Surgeries - Research and Markets

    Global Surgical Operating Microscopes Market (2016-2022) - Driven by Growth in Minimally Invasive Surgeries - Research and Markets

  6. Cystic Fibrosis Market 2015-2022 - Global Strategic Business Report 2017 - FDA Approves Vertex's ORKAMBI - Research and Markets

    Cystic Fibrosis Market 2015-2022 - Global Strategic Business Report 2017 - FDA Approves Vertex's ORKAMBI - Research and Markets

  7. Alexion Appoints Ludwig Hantson, Ph.D., as Chief Executive Officer

    Alexion Appoints Ludwig Hantson, Ph.D., as Chief Executive Officer

  8. AstraZeneca Gives Rejected Drugs a Second Life

    AstraZeneca Gives Rejected Drugs a Second Life

  9. Global $392.80 Billion Nanomedicine Market Drivers, Opportunities, Trends, and Forecasts, 2023 - Research and Markets

    Global $392.80 Billion Nanomedicine Market Drivers, Opportunities, Trends, and Forecasts, 2023 - Research and Markets

  10. World Market for Personalized Medicine Tests for Cancer 2017 - Research and Markets

    World Market for Personalized Medicine Tests for Cancer 2017 - Research and Markets

12345

©2017 Morningstar Advisor. All right reserved.